SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivimed Labs

BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 26, 16:00
74.85
-1.5 (-1.96%)
VOLUME 19,938
LIVE
NSE
Jul 26, 15:57
75.15
-1.35 (-1.76%)
VOLUME 52,885
Announcements on Vivimed Labs

26th-Jul-2016 12:15Source: NSE

Vivimed Labs Limited

: The Exchange had sought clarification from Vivimed Labs Limited with respect to announcement dated July 22, 2016, regarding press release dated July 22, 2016 title " Klar Sehen Private Limited, a wh...

22nd-Jul-2016 20:01Source: BSE

Vivimed Labs- Press Release

Vivimed Labs Ltd has informed BSE regarding a Press Release dated July 22, 2016 title "Klar Sehen Private Limited, a wholly owned subsidiary of Vivimed announces the sale of certain products along wit...

13th-Jul-2016 11:52Source: BSE

Vivimed Labs- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Vivimed Labs Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obl...

20th-Jun-2016 15:11Source: BSE

Vivimed Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Vijaykumar Varalwar has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

31st-May-2016 16:32Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has submitted to the Exchange a copy of the Corrigendum to Q4 and FY 2016 Results. (Revised)

31st-May-2016 15:37Source: BSE

Vivimed Labs- Earning Presentation

Vivimed Labs Ltd has submitted to BSE a copy of Earning Presentation - Q4 FY2016

31st-May-2016 15:31Source: BSE

Vivimed Labs- Corrigendum to Financial Results for March 2016

With Reference to the earlier announcement dated May 30, 2016, regarding Financial Results for March 31, 2016 Vivimed Labs Ltd has informed BSE that there is a type error in the Consolidated Segment R...

31st-May-2016 15:11Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding Vivimed Q4 FY2016 Earnings Presentation.

31st-May-2016 15:07Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding Conference Call with analysts/ investors post announcement of Q4 and full year FY2016 results.

31st-May-2016 13:05Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Manohar Rao Varalwar has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.